Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Rosiglitazone reduces hepatic...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Rosiglitazone reduces hepatic fat content
Bibliographic Details
Main Authors:
Buckingham, R
,
Toseland, C
,
Draper, N
,
Clarke, K
Format:
Journal article
Published:
2000
Holdings
Description
Similar Items
Staff View
Similar Items
Rosiglitazone prevents ischaemic injury in the obese Zucker rat heart
by: Sidell, R, et al.
Published: (2001)
Leukemia and rosiglitazone
by: Irfan Yavasoglu, et al.
Published: (2016-03-01)
Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.
by: How, O, et al.
Published: (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
by: Kahn, SE, et al.
Published: (2006)
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
by: Lygate, C, et al.
Published: (2003)